CreoPep: A Universal Deep Learning Framework for Target-Specific Peptide Design and Optimization

📅 2025-05-05
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Natural peptide variants—such as conotoxins—exhibit high sequence diversity, and conventional optimization methods are time-consuming, severely limiting the development of targeted peptide therapeutics. Method: We propose an end-to-end deep generative framework for *de novo* design and optimization of high-affinity, high-selectivity peptides. Our approach introduces progressive masked language modeling coupled with structure–function co-enhancement, breaking the canonical disulfide-bond dependency to generate peptides with non-canonical topologies and novel binding modes. It integrates FoldX-based energy filtering, temperature-controlled polynomial sampling, and multi-source data augmentation. Contribution/Results: We successfully designed sub-micromolar α7-nAChR-targeting conotoxin variants, validated experimentally via electrophysiology; cryo-EM and molecular dynamics simulations confirmed their distinct binding mechanisms. This framework substantially enhances both the efficiency and designability of therapeutic peptide discovery.

Technology Category

Application Category

📝 Abstract
Target-specific peptides, such as conotoxins, exhibit exceptional binding affinity and selectivity toward ion channels and receptors. However, their therapeutic potential remains underutilized due to the limited diversity of natural variants and the labor-intensive nature of traditional optimization strategies. Here, we present CreoPep, a deep learning-based conditional generative framework that integrates masked language modeling with a progressive masking scheme to design high-affinity peptide mutants while uncovering novel structural motifs. CreoPep employs an integrative augmentation pipeline, combining FoldX-based energy screening with temperature-controlled multinomial sampling, to generate structurally and functionally diverse peptides that retain key pharmacological properties. We validate this approach by designing conotoxin inhibitors targeting the $alpha$7 nicotinic acetylcholine receptor, achieving submicromolar potency in electrophysiological assays. Structural analysis reveals that CreoPep-generated variants engage in both conserved and novel binding modes, including disulfide-deficient forms, thus expanding beyond conventional design paradigms. Overall, CreoPep offers a robust and generalizable platform that bridges computational peptide design with experimental validation, accelerating the discovery of next-generation peptide therapeutics.
Problem

Research questions and friction points this paper is trying to address.

Designing high-affinity peptide mutants for target-specific applications
Overcoming limited natural diversity in therapeutic peptides
Integrating computational design with experimental validation efficiently
Innovation

Methods, ideas, or system contributions that make the work stand out.

Deep learning-based conditional generative framework
Integrative augmentation pipeline with energy screening
Generates diverse peptides retaining pharmacological properties
🔎 Similar Papers
No similar papers found.
C
Cheng Ge
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China
H
Han-Shen Tae
Molecular Horizons, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522 Australia
Z
Zhenqiang Zhang
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China
L
Lu Lu
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China
Z
Zhijie Huang
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China
Y
Yilin Wang
Faculty of Information Science and Engineering, Ocean University of China, Qingdao 266100, China
T
Tao Jiang
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China
Wenqing Cai
Wenqing Cai
Shandong Academy of Pharmaceutical Sciences, Jinan, China
Shan Chang
Shan Chang
Donghua University
securityprivacymobile networks
David J. Adams
David J. Adams
Distinguished Professor, University of Wollongong
PhysiologyPharmacologyNeuroscienceBiophysicsIon Channels
R
Rilei Yu
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China